PRONAV Clinical Expands to the U.S. with New Base at FITCI in Maryland
December 17, 2024
PRONAV Clinical is proud to announce the launch of its U.S. operations, marking a significant milestone in the company’s continued growth and global expansion. As part of the Maryland Global Gateway Soft Landing Program, PRONAV Clinical has officially joined the Frederick Innovative Technology Center, Inc. (FITCI), a premier incubator for life science and biotech innovation in the Mid-Atlantic region.
Founded in Ireland in 2019, PRONAV Clinical has built a reputation as a boutique clinical supply chain consultancy trusted by emerging biotech and pharmaceutical companies worldwide. Our expansion into the U.S. allows us to strengthen our global footprint while staying true to our mission: to accelerate the delivery of new therapeutics through precision, expertise, and collaboration.
“PRONAV Clinical was built to give smaller companies the personal attention they often can’t get from larger supply organizations. We’re excited to join FITCI’s dynamic community, where collaboration opportunities with fellow members, like Mesa Science Associates, allow us to offer a seamless, ‘one-stop shop’ solutions for companies navigating the drug development and clinical trial supply process.”
said Jim Kernan, Founder and CEO of PRONAV Clinical. As a new FITCI member, PRONAV gains access to a world-class network of partners, resources, and advisory services. The partnership also opens the door to deeper collaborations with local organizations—such as Mesa Science Associates—that complement our capabilities in regulatory, quality, and clinical supply chain operations. Together, we aim to provide integrated support for sponsors looking to streamline every aspect of early-phase drug development and trial supply.
FITCI CEO Kathie Callahan Brady commented on PRONAV Clinical’s arrival:
“Attracting international businesses like PRONAV Clinical strengthens our local economy and broadens the resources available to our business community. This diversity enriches the entrepreneurial ecosystem and boosts the viability of Frederick, and Maryland, as a global hub for life sciences innovation.”
With a 99.3% on-time delivery rate and a growing portfolio of U.S.-based clients, PRONAV Clinical is well-positioned for continued growth. Our entry into the U.S. market is projected to drive a 150% increase in revenue over the next two years, reflecting the strong demand for agile, expert-led clinical supply chain services.
As we expand our services and capabilities in the U.S., our commitment to boutique service, real-time responsiveness, and regulatory precision remains unchanged. This new chapter allows us to serve clients across both sides of the Atlantic with even greater efficiency and impact.
